Laboratory mice who were administered the compound labelled as GPHR-529 witnessed dramatic decline in semen. With this result in view, FDA is set to start trials for birth control pill for men soon.
The very first male birth control pill, which now has showed promising outcomes in lab tests, may be ready for human trials by the end of the year.
The contraceptive, developed by University of Minnesota scientists, has been shown to be 99 percent efficient in averting conception in rodents without any adverse effects. Instead of employing hormones, the tablet focuses on vitamin A interactions, which are important for conception.
(Hormonal tablets can cause weight gain and libido fluctuations, as well as lower "good" cholesterol concentrations, potentially causing cardiac problems.)
The researchers discovered that mice given the compound, termed GPHR-529, had a dramatic decline in semen, making them sterile after four weeks. When the medications were discontinued, the mice'...
Full Access
Included:
-
Access to All Articles.
-
One Plan. No Tiers.
-
No Ads.
-
Cancel anytime.
